The estimated Net Worth of Sean C. Flynn is at least $1.61 millió dollars as of 16 July 2024. Mr Flynn owns over 15,000 units of Vericel Corp stock worth over $686,396 and over the last 4 years he sold VCEL stock worth over $420,791. In addition, he makes $502,685 as VP és Gen. Counsel & Sec. at Vericel Corp.
Sign up
Mr Flynn VCEL stock SEC Form 4 insiders trading
Mr has made over 10 trades of the Vericel Corp stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 15,000 units of VCEL stock worth $243,750 on 16 July 2024.
The largest trade he's ever made was exercising 15,000 units of Vericel Corp stock on 16 July 2024 worth over $243,750. On average, Mr trades about 5,581 units every 84 days since 2021. As of 16 July 2024 he still owns at least 15,707 units of Vericel Corp stock.
You can see the complete history of Mr Flynn stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Sean C. Flynn biography
Sean C. Flynn is the VP, Gen. Counsel & Sec. at Vericel Corp.
What is the salary of Mr Flynn?
As the VP és Gen. Counsel & Sec. of Vericel Corp, the total compensation of Mr Flynn at Vericel Corp is $502,685. There are 6 executives at Vericel Corp getting paid more, with Dominick Colangelo having the highest compensation of $5,385,530.
How old is Mr Flynn?
Mr Flynn is 47, he's been the VP és Gen. Counsel & Sec. of Vericel Corp since . There are 12 older and 2 younger executives at Vericel Corp. The oldest executive at Vericel Corp is Robert Zerbe, 69, who is the Independent Chairman of the Board.
What's Mr Flynn's mailing address?
Sean's mailing address filed with the SEC is 64 SIDNEY STREET, , CAMBRIDGE, MA, 02139.
Insiders trading at Vericel Corp
Over the last 10 years, insiders at Vericel Corp have traded over $9,831,645 worth of Vericel Corp stock and bought 890 units worth $10,297 . The most active insiders traders include Dominick Colangelo, Gerard J Michel és Kevin F Mclaughlin. On average, Vericel Corp executives and independent directors trade stock every 17 days with the average trade being worth of $567,401. The most recent stock trade was executed by Steven C Gilman on 4 September 2024, trading 5,000 units of VCEL stock currently worth $18,700.
What does Vericel Corp do?
about vericel founded in 1989, vericel (formerly aastrom biosciences), is dedicated to the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. the company markets two cell therapy products in the united states, carticel® (autologous cultured chondrocytes), an autologous chondrocyte implant for the treatment of cartilage defects in the knee and epicel® (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. vericel is also developing maci, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee, and ixmyelocel-t, a patient specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (dcm). to fulfill vericel’s mission of helping people with severe diseases and conditions rea
What does Vericel Corp's logo look like?
Complete history of Mr Flynn stock trades at Vericel Corp
Vericel Corp executives and stock owners
Vericel Corp executives and other stock owners filed with the SEC include:
-
Dominick Colangelo,
President, Chief Executive Officer, Director -
Michael Halpin,
Chief Operating Officer -
Dominick C. Colangelo Esq.,
CEO, Pres & Director -
Michael Halpin,
Chief Operating Officer -
Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.,
Chief Medical Officer -
Dr. Jonathan M. Hopper,
Chief Medical Officer -
Sean C. Flynn,
VP, Gen. Counsel & Sec. -
Robert Zerbe,
Independent Chairman of the Board -
Alan Rubino,
Independent Director -
Kevin McLaughlin,
Independent Director -
Heidi Hagen,
Independent Director -
Steven Gilman,
Independent Director -
Paul Wotton,
Independent Director -
Sandra Pennell,
Principal Financial Officer and Principal Accounting Officer -
Jonathan Siegal,
Principal Accounting Officer, VP & Corp. Controller -
Roland DeAngelis,
Sr. VP of Commercial Operations -
Heidi Hassen,
VP of HR -
Patrick J. Fowler,
Sr. VP of Corp. Devel. & Strategy -
Eric Burns,
Exec. Director of Financial Planning and Analysis & Investor Relations -
Joseph Anthony Mara Jr.,
CFO, Principal Accounting Officer & Treasurer -
Capital Management Lp Conso...,
-
Daniel Orlando,
Chief Operating Officer -
Gerard J Michel,
CFO and VP, Corp. Development -
Nelson M Sims,
Director -
Lisa Wright,
-
Joseph Anthony Jr Mara,
Chief Financial Officer -
Jonathan Siegal,
Principal Accounting Officer -
Jonathan Mark Hopper,
Chief Medical Officer -
Sean C. Flynn,
Chief Legal Officer